Stock 4126 PACIFIC HOSPITAL SUPPLY CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pacific Hospital Supply Co., Ltd

Equities

4126

TW0004126008

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 28/04/2024 BST 		5-day change 1st Jan Change
91 TWD 0.00% Intraday chart for Pacific Hospital Supply Co., Ltd +1.00% +5.32%
03-01 Pacific Hospital Supply Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Pacific Hospital Supply Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 4,905 5,082 5,452 5,481 6,273 6,607 -
Enterprise Value (EV) 1 4,905 4,865 4,867 4,793 6,273 5,764 5,608
P/E ratio 10.7 x 15.6 x 14.2 x 16.6 x 14.9 x 16 x 15 x
Yield - 6% 5.99% 5.56% - 5.6% 5.99%
Capitalization / Revenue 2.4 x 2.34 x 2.7 x 2.51 x 2.7 x 2.81 x 2.66 x
EV / Revenue 2.4 x 2.24 x 2.41 x 2.19 x 2.7 x 2.45 x 2.26 x
EV / EBITDA - 7.96 x 10.3 x 9.53 x 9.79 x 9.25 x 8.52 x
EV / FCF 19.3 x 9.66 x 16.9 x 12 x - 11.3 x 10.7 x
FCF Yield 5.18% 10.4% 5.92% 8.37% - 8.83% 9.38%
Price to Book 1.92 x 1.94 x 2.02 x 2.02 x - 2.28 x 2.23 x
Nbr of stocks (in thousands) 72,600 72,600 72,600 72,600 72,600 72,600 -
Reference price 2 67.56 70.00 75.10 75.50 86.40 91.00 91.00
Announcement Date 26/02/20 25/02/21 25/02/22 24/02/23 01/03/24 - -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 2,041 2,172 2,019 2,185 2,320 2,354 2,480
EBITDA 1 - 610.9 473.9 502.9 640.9 623 658
EBIT 1 347.3 440.9 313.4 354.5 498 481 517
Operating Margin 17.02% 20.3% 15.52% 16.22% 21.46% 20.43% 20.85%
Earnings before Tax (EBT) 1 529.8 422.7 434 413.5 525.5 515 550
Net income 1 459.1 328.7 386.4 331.4 420.8 412 440
Net margin 22.5% 15.14% 19.14% 15.17% 18.14% 17.5% 17.74%
EPS 2 6.292 4.500 5.290 4.540 5.800 5.670 6.060
Free Cash Flow 1 253.8 503.8 288.3 401 - 509 526
FCF margin 12.44% 23.19% 14.28% 18.35% - 21.62% 21.21%
FCF Conversion (EBITDA) - 82.47% 60.85% 79.73% - 81.7% 79.94%
FCF Conversion (Net income) 55.29% 153.25% 74.62% 120.99% - 123.54% 119.55%
Dividend per Share 2 - 4.200 4.500 4.200 - 5.100 5.450
Announcement Date 26/02/20 25/02/21 25/02/22 24/02/23 01/03/24 - -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 465.8 485.7 495.5 488.7 583.2 617.6 626.3 593.4 580.7 519.8 578 584 587 604
EBITDA - - - - - - - - - - - - - -
EBIT 1 66.83 55.23 55.56 66.06 110.9 121.9 139 126.8 124.6 107.7 117 119 120 126
Operating Margin 14.35% 11.37% 11.21% 13.52% 19.02% 19.75% 22.19% 21.36% 21.46% 20.72% 20.24% 20.38% 20.44% 20.86%
Earnings before Tax (EBT) 1 215.7 50.3 70.21 73.92 141.2 128.1 142.4 137.1 154.8 91.15 125 127 128 134
Net income 1 205.7 40.46 55.96 58.81 112.9 103.7 113.6 110.5 123.8 72.91 100 102 103 107
Net margin 44.15% 8.33% 11.29% 12.03% 19.37% 16.79% 18.13% 18.62% 21.32% 14.03% 17.3% 17.47% 17.55% 17.72%
EPS 2 2.820 0.5400 0.7700 0.8100 1.550 1.420 1.560 1.520 1.700 1.010 1.380 1.400 1.410 1.480
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 04/11/21 25/02/22 06/05/22 05/08/22 10/11/22 24/02/23 09/05/23 09/08/23 09/11/23 01/03/24 - - - -
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - -
Net Cash position 1 - 217 585 688 - 843 999
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 254 504 288 401 - 509 526
ROE (net income / shareholders' equity) 18.9% 12.7% 14.5% 12.2% - 14.2% 14.8%
ROA (Net income/ Total Assets) 12.2% 8.32% 9.98% 8.91% - 11% 11.5%
Assets 1 3,768 3,949 3,872 3,721 - 3,745 3,826
Book Value Per Share 2 35.10 36.00 37.30 37.40 - 39.90 40.90
Cash Flow per Share - - - - - - -
Capex 1 207 66.6 30.8 30.7 - 27 27
Capex / Sales 10.17% 3.07% 1.52% 1.41% - 1.15% 1.09%
Announcement Date 26/02/20 25/02/21 25/02/22 24/02/23 01/03/24 - -
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pacific Hospital Supply Co., Ltd

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
91 TWD
Average target price
96 TWD
Spread / Average Target
+5.49%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

1st Jan change Capi.
PACIFIC HOSPITAL SUPPLY CO., LTD Stock Pacific Hospital Supply Co., Ltd
+5.32% 203M
COLOPLAST A/S Stock Coloplast A/S
+11.63% 27.84B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-30.09% 3.04B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-14.68% 2.56B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+11.64% 2.33B
HARTALEGA HOLDINGS Stock Hartalega Holdings
+2.96% 1.99B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-11.65% 1.87B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
-1.67% 1.49B
NAKANISHI INC. Stock Nakanishi Inc.
+2.19% 1.27B
KANGJI MEDICAL HOLDINGS LIMITED Stock Kangji Medical Holdings Limited
+3.29% 1.12B
Medical Supplies
  1. Stock Market
  2. Equities
  3. 4126 Stock
  4. Financials Pacific Hospital Supply Co., Ltd